BJA Advance Access published online on May 27, 2005
British Journal of Anaesthesia, doi:10.1093/bja/aei160
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Department of Anaesthesiology and Critical Care Medicine, Innsbruck Medical University, Austria
* To whom correspondence should be addressed. Background. This study was conducted to determine whether replacement of fibrinogen is useful in reversing dilutional coagulopathy following severe haemorrhage and administration of colloids. Methods. In 14 anaesthetized pigs, approximately 65% of the estimated blood volume was withdrawn and replaced with the same amount of gelatin solution to achieve dilutional coagulopathy. Animals were randomized to receive either 250 mg kg-1 fibrinogen (n=7) or normal saline (n=7). A standardized liver injury was then inflicted to induce uncontrolled haemorrhage. Modified thrombelastography and standard coagulation tests were performed at baseline, after blood withdrawal, after dilution, after injection of the study drugs, and on conclusion of the protocol. Further, electron microscopy imaging of the blood clots was performed and blood loss after liver injury was determined. Results. Severely impaired haemostasis was observed after haemodilution with gelatin substitution. With administration of fibrinogen, clot firmness and dynamics of clot formation reached baseline values. Median blood loss following liver injury was significantly less (P=0.018) in the fibrinogen-treated animals (1100 ml; 800-1400 ml) than in the placebo group (2010 ml; 1800-2200 ml). Conclusions. Replacing 65% of the estimated blood volume with gelatin in swine resulted in dilutional coagulopathy; subsequent fibrinogen administration improved clot formation and reduced blood loss significantly.
Accepted April 20, 2005
Laboratory Investigation
Effect of fibrinogen on reversal of dilutional coagulopathy: a porcine model
2 Department of Theoretical Surgery, Innsbruck Medical University, Austria
3 Department of Paediatrics, Innsbruck Medical University, Austria
4 Department of Histology, Innsbruck Medical University, Austria; Department of Embryology, Innsbruck Medical University, Austria
D. Fries, E-mail: dietmar.fries{at}uibk.ac.at
Abstract 
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  W. C. Oliver Anticoagulation and Coagulation Management for ECMO Seminars in Cardiothoracic and Vascular Anesthesia, September 1, 2009; 13(3): 154 - 175. [Abstract] [PDF]
|
|
|
|
 |
|
 D. Bolliger, F. Szlam, R. J. Molinaro, N. Rahe-Meyer, J. H. Levy, and K. A. Tanaka Finding the optimal concentration range for fibrinogen replacement after severe haemodilution: an in vitro model Br. J. Anaesth., June 1, 2009; 102(6): 793 - 799. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Lang, K. Johanning, H. Metzler, S. Piepenbrock, C. Solomon, N. Rahe-Meyer, and K. A. Tanaka The Effects of Fibrinogen Levels on Thromboelastometric Variables in the Presence of Thrombocytopenia Anesth. Analg., March 1, 2009; 108(3): 751 - 758. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. B. A. MacLeod Trauma and Coagulopathy: A New Paradigm to Consider Arch Surg, August 1, 2008; 143(8): 797 - 801. [Full Text] [PDF]
|
|
|
|
|
|
T. Haas, D. Fries, C. Velik-Salchner, C. Reif, A. Klingler, and P. Innerhofer The In Vitro Effects of Fibrinogen Concentrate, Factor XIII and Fresh Frozen Plasma on Impaired Clot Formation After 60% Dilution Anesth. Analg., May 1, 2008; 106(5): 1360 - 1365. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. T. Ganter and C. K. Hofer Coagulation Monitoring: Current Techniques and Clinical Use of Viscoelastic Point-of-Care Coagulation Devices Anesth. Analg., May 1, 2008; 106(5): 1366 - 1375. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. McDonald and K. Ryland Coagulopathy in trauma: optimising haematological status Trauma, April 1, 2008; 10(2): 109 - 123. [Abstract] [PDF]
|
|
|
|
|
|
G. Dickneite, B. Doerr, and F. Kaspereit Characterization of the Coagulation Deficit in Porcine Dilutional Coagulopathy and Substitution with a Prothrombin Complex Concentrate Anesth. Analg., April 1, 2008; 106(4): 1070 - 1077. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Haas, D. Fries, C. Holz, P. Innerhofer, W. Streif, A. Klingler, A. Hanke, and C. Velik-Salchner Less Impairment of Hemostasis and Reduced Blood Loss in Pigs After Resuscitation from Hemorrhagic Shock Using the Small-Volume Concept with Hypertonic Saline/Hydroxyethyl Starch as Compared to Administration of 4% Gelatin or 6% Hydroxyethyl Starch Solution Anesth. Analg., April 1, 2008; 106(4): 1078 - 1086. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. A. Tanaka, T. Taketomi, F. Szlam, A. Calatzis, and J. H. Levy Improved Clot Formation by Combined Administration of Activated Factor VII (NovoSeven(R)) and Fibrinogen (Haemocomplettan(R) P) Anesth. Analg., March 1, 2008; 106(3): 732 - 738. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Mittermayr, W. Streif, T. Haas, D. Fries, C. Velik-Salchner, A. Klingler, E. Oswald, C. Bach, M. Schnapka-Koepf, and P. Innerhofer Hemostatic Changes After Crystalloid or Colloid Fluid Administration During Major Orthopedic Surgery: The Role of Fibrinogen Administration Anesth. Analg., October 1, 2007; 105(4): 905 - 917. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Fries, T. Haas, A. Klingler, W. Streif, G. Klima, J. Martini, H. Wagner-Berger, and P. Innerhofer Efficacy of fibrinogen and prothrombin complex concentrate used to reverse dilutional coagulopathy--a porcine model Br. J. Anaesth., October 1, 2006; 97(4): 460 - 467. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. De Lorenzo, A. Calatzis, U. Welsch, and B. Heindl Fibrinogen concentrate reverses dilutional coagulopathy induced in vitro by saline but not by hydroxyethyl starch 6%. Anesth. Analg., April 1, 2006; 102(4): 1194 - 1200. [Abstract] [Full Text] [PDF]
|
|